» Articles » PMID: 33189359

Extracellular Vesicles: A Bright Star of Nanomedicine

Overview
Journal Biomaterials
Date 2020 Nov 15
PMID 33189359
Citations 150
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) have unique structural, compositional, and morphological characteristics as well as predominant physiochemical stability and biocompatibility properties. They play a crucial role in pathophysiological regulation, and also have broad prospects for clinical application in the diagnosis, prognosis, and therapy of disease, and tissue regeneration and repair. Herein, the biosynthesis and physiological functions and current methods for separation and identification of EVs are summarized. Specifically, engineered EVs may be used to enhance targeted therapy in cancer and repair damaged tissues, and they may be developed as an individualized imaging diagnostic reagent, among other potential applications. We will focus on reviewing recent studies on engineered EVs in which alterations enhanced their therapeutic capability or diagnostic imaging potential via physical, chemical, and biological modification approaches. This review will clarify the superior biological functions and powerful therapeutic potential of EVs, particularly with regard to new designs based on EVs and their utilization in a new generation of nanomedicine diagnosis and treatment platforms.

Citing Articles

Emerging Frontiers in acute kidney injury: The role of extracellular vesicles.

Li S, Zhou L, Huang Y, Tang S Bioact Mater. 2025; 48:149-170.

PMID: 40046015 PMC: 11880721. DOI: 10.1016/j.bioactmat.2025.02.018.


Therapeutic role of hucMSC-sEV-enriched miR-13896 in cisplatin-induced acute kidney injury through M2 macrophage polarization.

Jin C, Wu P, Wu W, Chen W, Liu W, Zhu Y Cell Biol Toxicol. 2025; 41(1):50.

PMID: 39992453 PMC: 11850457. DOI: 10.1007/s10565-025-09998-2.


Roles, Functions, and Pathological Implications of Exosomes in the Central Nervous System.

Spinelli S, Tripodi D, Corti N, Zocchi E, Bruschi M, Leoni V Int J Mol Sci. 2025; 26(3).

PMID: 39941112 PMC: 11818369. DOI: 10.3390/ijms26031345.


Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy.

Jiang Y, Wei Z, Song Z, Yu M, Huang J, Qian H Drug Deliv Transl Res. 2025; .

PMID: 39873880 DOI: 10.1007/s13346-025-01792-1.


Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment.

Zheng L, Chang R, Liang B, Wang Y, Zhu Y, Jia Z Cancer Drug Resist. 2025; 7():50.

PMID: 39802949 PMC: 11724354. DOI: 10.20517/cdr.2024.107.